Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.
2.

Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent.

Gaudreault E, Gosselin J.

Viral Immunol. 2007 Sep;20(3):407-20.

PMID:
17931111
3.

Leukotriene B4 potentiates CpG signaling for enhanced cytokine secretion by human leukocytes.

Gaudreault E, Gosselin J.

J Immunol. 2009 Aug 15;183(4):2650-8. doi: 10.4049/jimmunol.0804135. Epub 2009 Jul 20.

4.

Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents.

Flamand L, Tremblay MJ, Borgeat P.

J Immunol. 2007 Jun 15;178(12):8036-45.

5.

Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival.

Stankova J, Turcotte S, Harris J, Rola-Pleszczynski M.

J Immunol. 2002 Apr 1;168(7):3570-6.

6.
7.

Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6.

Kavelaars A, Vroon A, Raatgever RP, Fong AM, Premont RT, Patel DD, Lefkowitz RJ, Heijnen CJ.

J Immunol. 2003 Dec 1;171(11):6128-34.

8.

Release of anti-HIV mediators after administration of leukotriene B4 to humans.

Flamand L, Borgeat P, Lalonde R, Gosselin J.

J Infect Dis. 2004 Jun 1;189(11):2001-9. Epub 2004 Apr 30.

PMID:
15143466
9.
10.

Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.

Wan M, Godson C, Guiry PJ, Agerberth B, Haeggström JZ.

FASEB J. 2011 May;25(5):1697-705. doi: 10.1096/fj.10-175687. Epub 2011 Feb 9.

PMID:
21307335
11.

Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y.

J Immunol. 2007 Feb 15;178(4):2448-57.

12.

Leukotriene B4-loaded microspheres as a new approach to enhance antimicrobial responses in Histoplasma capsulatum-infected mice.

Nicolete R, Secatto A, Pereira PA, Soares EG, Faccioli LH.

Int J Antimicrob Agents. 2009 Oct;34(4):365-9. doi: 10.1016/j.ijantimicag.2009.06.009. Epub 2009 Jul 14.

PMID:
19604676
13.

Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin).

Di Gennaro A, Kenne E, Wan M, Soehnlein O, Lindbom L, Haeggström JZ.

FASEB J. 2009 Jun;23(6):1750-7. doi: 10.1096/fj.08-121277. Epub 2009 Jan 16.

PMID:
19151333
14.

Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses.

Wan M, Sabirsh A, Wetterholm A, Agerberth B, Haeggström JZ.

FASEB J. 2007 Sep;21(11):2897-905. Epub 2007 Apr 19.

PMID:
17446260
15.
16.
17.

Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures.

Liu A, Claesson HE, Mahshid Y, Klein G, Klein E.

Blood. 2008 Mar 1;111(5):2693-703. Epub 2007 Dec 19.

18.

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4331-7. doi: 10.1128/AAC.00506-08. Epub 2008 Sep 29.

19.

Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.

Batra S, Cai S, Balamayooran G, Jeyaseelan S.

J Immunol. 2012 Apr 1;188(7):3458-68. doi: 10.4049/jimmunol.1101985. Epub 2012 Feb 29.

20.

RhoH/TTF negatively regulates leukotriene production in neutrophils.

Daryadel A, Yousefi S, Troi D, Schmid I, Schmidt-Mende J, Mordasini C, Dahinden CA, Ziemiecki A, Simon HU.

J Immunol. 2009 May 15;182(10):6527-32. doi: 10.4049/jimmunol.0803846.

Supplemental Content

Support Center